Publication

Article

Specialty Pharmacy Times
July/August 2015
Volume 6
Issue 4

Understanding the Impact of the Specialty Pharmacist on Quality and Effective Medication Management in Multiple Sclerosis

Understanding the Impact of the Specialty Pharmacist on Quality and Effective Medication Management in Multiple Sclerosis

Sarah Anderson, PharmD

Clinical Program Pharmacist

Medica Health Plans

Minnetonka, Minnesota

Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP

Director of Specialty Clinical Services

Managed Health Care Associates, Inc (MHA)

Florham Park, New Jersey

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose.

Faculty

Sarah Anderson, PharmD, and Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP

Pharmacy Times Office of Continuing Professional Education Planning StaffDavid Heckard; Maryjo Dixon, RPh; Dipti Desai, PharmD, RPh; Donna Fausak; and Nathalie Harden

Specialty Pharmacy Times Editorial StaffDavy James

An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Objectives

After participating in this activity, participants should be able to:

  • Explain the pathophysiology, clinical presentation, and economic burden associated with MS
  • Illustrate current treatment options for MS and emerging therapies
  • Analyze potential opportunities for the specialty pharmacist to provide disease awareness through effective patient education to optimize adherence and improve outcomes

Target audience: Pharmacists

Type of activity: Application

Release date: August 12, 2015

Expiration date: August 12, 2016

Estimated time to complete activity: 1.0 hours

Fee: This lesson is offered for free at www.pharmacytimes.org.

https://www.pharmacytimes.org/landing/688

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.1 CEU) under the ACPE universal activity number 0290-0000-15-088-H01-P. The activity is available for CE credit through August 12, 2016.

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs